Phase I, Randomized, Open-Label, 2-Way Crossover Study to Evaluate Relative Bioavailability of Single Oral Dose of Celecoxib Administered as Marketed Product, or Overencapsulated Capsule in Healthy Volunteers.

Trial Profile

Phase I, Randomized, Open-Label, 2-Way Crossover Study to Evaluate Relative Bioavailability of Single Oral Dose of Celecoxib Administered as Marketed Product, or Overencapsulated Capsule in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2010

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Ankylosing spondylitis; Gouty arthritis; Juvenile rheumatoid arthritis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors POZEN
  • Most Recent Events

    • 15 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 May 2009 Actual end date (October 2008) added as reported by ClinicalTrials.gov.
    • 26 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top